Literature DB >> 34016165

Variation in the vulnerability of mice expressing human superoxide dismutase 1 to prion-like seeding: a study of the influence of primary amino acid sequence.

Jacob I Ayers1,2,3, Guilian Xu1, Kristy Dillon1, Qing Lu1, Zhijuan Chen1, John Beckman4, Alma K Moreno-Romero4, Diana L Zamora4, Ahmad Galaleldeen4, David R Borchelt5,6.   

Abstract

Misfolded forms of superoxide dismutase 1 (SOD1) with mutations associated with familial amyotrophic lateral sclerosis (fALS) exhibit prion characteristics, including the ability to act as seeds to accelerate motor neuron disease in mouse models. A key feature of infectious prion seeding is that the efficiency of transmission is governed by the primary sequence of prion protein (PrP). Isologous seeding, where the sequence of the PrP in the seed matches that of the host, is generally much more efficient than when there is a sequence mis-match. Here, we used paradigms in which mutant SOD1 seeding homogenates were injected intraspinally in newborn mice or into the sciatic nerve of adult mice, to assess the influence of SOD1 primary sequence on seeding efficiency. We observed a spectrum of seeding efficiencies depending upon both the SOD1 expressed by mice injected with seeds and the origin of the seed preparations. Mice expressing WT human SOD1 or the disease variant G37R were resistant to isologous seeding. Mice expressing G93A SOD1 were also largely resistant to isologous seeding, with limited success in one line of mice that express at low levels. By contrast, mice expressing human G85R-SOD1 were highly susceptible to isologous seeding but resistant to heterologous seeding by homogenates from paralyzed mice over-expressing mouse SOD1-G86R. In other seeding experiments with G85R SOD1:YFP mice, we observed that homogenates from paralyzed animals expressing the H46R or G37R variants of human SOD1 were less effective than seeds prepared from mice expressing the human G93A variant. These sequence mis-match effects were less pronounced when we used purified recombinant SOD1 that had been fibrilized in vitro as the seeding preparation. Collectively, our findings demonstrate diversity in the abilities of ALS variants of SOD1 to initiate or sustain prion-like propagation of misfolded conformations that produce motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34016165      PMCID: PMC8139116          DOI: 10.1186/s40478-021-01191-w

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.578


  62 in total

1.  Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis.

Authors:  Leslie I Grad; Neil R Cashman
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

2.  Retrograde transport of transmissible mink encephalopathy within descending motor tracts.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds.

Authors:  T Ratovitski; L B Corson; J Strain; P Wong; D W Cleveland; V C Culotta; D R Borchelt
Journal:  Hum Mol Genet       Date:  1999-08       Impact factor: 6.150

4.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

5.  Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein.

Authors:  K K Hsiao; D Groth; M Scott; S L Yang; H Serban; D Rapp; D Foster; M Torchia; S J Dearmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis.

Authors:  Xiaohang Cao; Svetlana V Antonyuk; Sai V Seetharaman; Lisa J Whitson; Alexander B Taylor; Stephen P Holloway; Richard W Strange; Peter A Doucette; Joan Selverstone Valentine; Ashutosh Tiwari; Lawrence J Hayward; Shelby Padua; Jeffrey A Cohlberg; S Samar Hasnain; P John Hart
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

7.  Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice.

Authors:  Dick Jaarsma; Eva Teuling; Elize D Haasdijk; Chris I De Zeeuw; Casper C Hoogenraad
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

8.  Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD.

Authors:  Jared R Williams; Emiliano Trias; Pamela R Beilby; Nathan I Lopez; Edwin M Labut; C Samuel Bradford; Blaine R Roberts; Erin J McAllum; Peter J Crouch; Timothy W Rhoads; Cliff Pereira; Marjatta Son; Jeffrey L Elliott; Maria Clara Franco; Alvaro G Estévez; Luis Barbeito; Joseph S Beckman
Journal:  Neurobiol Dis       Date:  2016-01-27       Impact factor: 5.996

9.  Novel SOD1 monoclonal antibodies against the electrostatic loop preferentially detect misfolded SOD1 aggregates.

Authors:  Yuxing Xia; Zhijuan Chen; Guilian Xu; David R Borchelt; Jacob I Ayers; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-12-17       Impact factor: 3.197

10.  Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis.

Authors:  Jeffrey S Deitch; Guillermo M Alexander; Andrew Bensinger; Steven Yang; Juliann T Jiang; Terry D Heiman-Patterson
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more
  1 in total

Review 1.  Prionoids in amyotrophic lateral sclerosis.

Authors:  Philippe Gosset; William Camu; Cedric Raoul; Alexandre Mezghrani
Journal:  Brain Commun       Date:  2022-06-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.